Economic burden of generalized pustular psoriasis and palmoplantar pustulosis in the United States.

Maya L HannaDavid SingerWendell C Valdecantos

Published in: Current medical research and opinion (2021)

GPP and PPP patients have significant economic burden due to higher direct medical and pharmacy costs. Further investigation is needed to better understand the drivers of economic burden in patients with GPP and PPP, and how HCRU and costs are impacted by disease severity.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
healthcare
peritoneal dialysis
prognostic factors
patient reported
atopic dermatitis